CANbridge Pharmaceuticals Appoints General Manager of China
Dec 22, 2020
CANbridge Pharmaceuticals CAN106 Investigational New Drug Application Approved in Singapore for the Treatment of Complement Dysregulation Diseases
Dec 18, 2020
CANbridge Pharmaceuticals Completes $43 Million Series E Financing
Dec 02, 2020
CANbridge Pharmaceuticals Appoints Head of Global Research
Oct 27, 2020
CANbridge Pharmaceuticals Receives Chinese Marketing Approval for Hunterase® First Enzyme Replacement Therapy for Hunter Syndrome in China
Sep 10, 2020
CANbridge Pharmaceuticals Enters into Second Rare Disease Gene Therapy Research Agreement with UMass Medical School
Sep 09, 2020
CANbridge Pharmaceuticals Receives Marketing Approval for Nerlynx® (Neratinib) in Taiwan
Aug 07, 2020
CANbridge Pharmaceuticals Appoints Senior Vice President/Global Head of Business Development
Jun 16, 2020
CANbridge Pharmaceuticals Enters into Rare Disease Gene Therapy Research Agreement with UMass Medical School
Jun 09, 2020